Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine with Carfilzomib and Dexamethasone in RRMM
NCT04813653Phase 1Completed
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Apr 2021
- Primary completion
- Mar 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cyclosporine in multiple myeloma (MM), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Number of Participants With Abnormal Laboratory Values and/or Adverse Events That Are Related to Treatment parameters at 2 years. Started Apr 2021; status: completed.
02
Drugs
cyclosporine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04813653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04813653.